Effects of Streptozocin Diabetes and Diabetes Treatment by Islet Transplantation on In Vivo Insulin Signaling in Rat Heart

Effects of Streptozocin Diabetes and Diabetes Treatment by Islet Transplantation on In Vivo Insulin Signaling in Rat Heart Luigi Laviola 1 , Gaetana Belsanti 1 , Alberto M. Davalli 2 , Raffaele Napoli 2 , Sebastio Perrini 1 , Gordon C. Weir 2 , Riccardo Giorgino 1 and Francesco Giorgino 1 1 Internal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2001-12, Vol.50 (12), p.2709-2720
Hauptverfasser: LAVIOLA, Luigi, BELSANTI, Gaetana, DAVALLI, Alberto M, NAPOLI, Raffaele, PERRINI, Sebastio, WEIR, Gordon C, GIORGINO, Riccardo, GIORGINO, Francesco
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Effects of Streptozocin Diabetes and Diabetes Treatment by Islet Transplantation on In Vivo Insulin Signaling in Rat Heart Luigi Laviola 1 , Gaetana Belsanti 1 , Alberto M. Davalli 2 , Raffaele Napoli 2 , Sebastio Perrini 1 , Gordon C. Weir 2 , Riccardo Giorgino 1 and Francesco Giorgino 1 1 Internal Medicine, Endocrinology and Metabolic Diseases, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy 2 Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts Abstract The insulin signaling cascade was investigated in rat myocardium in vivo in the presence of streptozocin (STZ)-induced diabetes and after diabetes treatment by islet transplantation under the kidney capsule. The levels of insulin-stimulated tyrosine phosphorylation of the insulin receptor β-subunit, insulin receptor substrate (IRS)-2, and p52 Shc were increased in diabetic compared with control heart, whereas tyrosine phosphorylation of IRS-1 was unchanged. The amount of the p85 subunit of phosphatidylinositol 3-kinase (PI 3-kinase) and the level of PI 3-kinase activity associated with IRS-2 were also elevated in diabetes, whereas no changes in IRS-1–associated PI 3-kinase were observed. Insulin-induced phosphorylation of Akt on Thr-308 was increased fivefold in diabetic heart, whereas Akt phosphorylation on Ser-473 was normal. In contrast with Akt phosphorylation, insulin-induced phosphorylation of glycogen synthase kinase (GSK)-3, a major cellular substrate of Akt, was markedly reduced in diabetes. In islet-transplanted rats, the majority of the alterations in insulin-signaling proteins found in diabetic rats were normalized, but insulin stimulation of IRS-2 tyrosine phosphorylation and association with PI 3-kinase was blunted. In conclusion, in the diabetic heart, 1 ) IRS-1, IRS-2, and p52 Shc are differently altered, 2 ) the levels of Akt phosphorylation on Ser-473 and Thr-308, respectively, are not coordinately regulated, and 3 ) the increased activity of proximal-signaling proteins (i.e., IRS-2 and PI 3-kinase) is not propagated distally to GSK-3. Islet transplantation under the kidney capsule is a potentially effective therapy to correct several diabetes-induced abnormalities of insulin signaling in cardiac muscle but does not restore the responsiveness of all signaling reactions to insulin. Footnotes Address correspondence and reprint requests to Francesco Giorgino, MD, PhD, Internal Medicine, Endocrinology and Metabolic Diseases, Department of
ISSN:0012-1797
1939-327X
DOI:10.2337/diabetes.50.12.2709